Cargando…
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
SIMPLE SUMMARY: The field of liquid biopsy is rapidly evolving. Techniques that improve accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a tool to guide their clinical practice. The assessment of minimal or microscopic residual disease (MRD) after oncological...
Autores principales: | Honoré, Natasha, Galot, Rachel, van Marcke, Cédric, Limaye, Nisha, Machiels, Jean-Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582541/ https://www.ncbi.nlm.nih.gov/pubmed/34771526 http://dx.doi.org/10.3390/cancers13215364 |
Ejemplares similares
-
Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023) -
Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
por: Colmenares, Rafael, et al.
Publicado: (2022) -
Epigenetic liquid biopsies for minimal residual disease, what’s around the corner?
por: Johnston, Andrew D., et al.
Publicado: (2023) -
Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip
por: Khoo, Bee Luan, et al.
Publicado: (2019)